» Articles » PMID: 23386849

The Linkage of Innate and Adaptive Immune Response During Granulomatous Development

Overview
Journal Front Immunol
Date 2013 Feb 7
PMID 23386849
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Granulomas represent a spectrum of inflammatory sequestration responses that may be initiated by a variety of agents, including non-infectious environmental factors and infectious microbial pathogens. Although this reaction is designed to be protective, the associated tissue injury is often responsible for a profound degree of pathology. While many of the mechanisms that sustain the development of the granuloma are enigmatic, it is accepted that the maintenance of this inflammatory process is dependent upon dynamic interactions between an inciting agent, inflammatory mediators, various immune and inflammatory cells, and structural cells of the involved tissue. The best studied of the host-dependent processes during granuloma development is the innate and adaptive immune response. The innate immune response by antigen-presenting cells [APCs; dendritic cells (DCs) and macrophages] is initiated quickly to protect from overwhelming pathogens, but with time, can also activate the adaptive immune response. APCs, essential regulators of the innate immune response, can respond to microbial ligands through Toll-like receptors (TLRs), which function in the recognition of microbial components and play an important role to link the innate and adaptive immune responses. CD4(+) T helper (Th) cells are essential regulators of adaptive immune responses and inflammatory diseases. Recently, the Notch system has been shown to be an important bridge between APCs and T cell communication circuits. In the present review, we discuss recent findings that explore the mechanisms in the linkage of innate and adaptive immunity, including granulomatous formation though TLRs and Notch activation.

Citing Articles

Characterization of polarization states of canine monocyte derived macrophages.

Lyu Q, Veldhuizen E, Ludwig I, Rutten V, van Eden W, Sijts A PLoS One. 2023; 18(11):e0292757.

PMID: 37939066 PMC: 10631683. DOI: 10.1371/journal.pone.0292757.


Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy.

Voicu V, Brehar F, Toader C, Covache-Busuioc R, Corlatescu A, Bordeianu A Biomolecules. 2023; 13(9).

PMID: 37759788 PMC: 10526757. DOI: 10.3390/biom13091388.


Innate Immune Memory in Macrophages.

Maheshwari A Newborn (Clarksville). 2023; 2(1):60-79.

PMID: 37206580 PMC: 10193650. DOI: 10.5005/jp-journals-11002-0058.


Regulation of intrinsic and extrinsic metabolic pathways in tumour-associated macrophages.

Davuluri G, Chan C FEBS J. 2022; 290(12):3040-3058.

PMID: 35486022 PMC: 10711806. DOI: 10.1111/febs.16465.


Assessment of the toxicity and carcinogenicity of double-walled carbon nanotubes in the rat lung after intratracheal instillation: a two-year study.

Saleh D, Luo S, Ahmed O, Alexander D, Alexander W, Gunasekaran S Part Fibre Toxicol. 2022; 19(1):30.

PMID: 35449069 PMC: 9026941. DOI: 10.1186/s12989-022-00469-8.


References
1.
Kumar H, Kawai T, Akira S . Pathogen recognition by the innate immune system. Int Rev Immunol. 2011; 30(1):16-34. DOI: 10.3109/08830185.2010.529976. View

2.
Chensue S, Warmington K, Ruth J, Lincoln P, Kuo M, Kunkel S . Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol. 1994; 145(5):1105-13. PMC: 1887419. View

3.
Herbert D, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M . Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004; 20(5):623-35. DOI: 10.1016/s1074-7613(04)00107-4. View

4.
Mosser D, Edwards J . Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8(12):958-69. PMC: 2724991. DOI: 10.1038/nri2448. View

5.
Silva Miranda M, Breiman A, Allain S, Deknuydt F, Altare F . The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?. Clin Dev Immunol. 2012; 2012:139127. PMC: 3395138. DOI: 10.1155/2012/139127. View